The present invention relates to Tumor necrosis factor related ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, and pharmaceutical compositions comprising them.

 
Web www.patentalert.com

< Methods of treating crohn's disease with anti-TNF antibodies

< Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof

> Antibodies to human tumor necrosis factor receptor-like genes

> Variants of traf2 which act as an inhibitor of tnf-alpha (tnf) signaling pathway
~ 00299